Properties of HIV envelope expressed in the presence of SPC3, an Env-derived peptide drug under phase II clinical trials.
Barbouche, R
Properties of HIV envelope expressed in the presence of SPC3, an Env-derived peptide drug under phase II clinical trials. [electronic resource] - The journal of peptide research : official journal of the American Peptide Society Oct 1998 - 283-8 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1397-002X
10.1111/j.1399-3011.1998.tb01242.x doi
AIDS Vaccines--chemistry
Binding Sites
Cells, Cultured
Clinical Trials, Phase II as Topic
HIV Envelope Protein gp120--chemistry
HIV Infections--prevention & control
HIV-1--chemistry
Humans
Peptide Fragments--chemistry
Protein Conformation
Receptors, HIV--antagonists & inhibitors
Properties of HIV envelope expressed in the presence of SPC3, an Env-derived peptide drug under phase II clinical trials. [electronic resource] - The journal of peptide research : official journal of the American Peptide Society Oct 1998 - 283-8 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1397-002X
10.1111/j.1399-3011.1998.tb01242.x doi
AIDS Vaccines--chemistry
Binding Sites
Cells, Cultured
Clinical Trials, Phase II as Topic
HIV Envelope Protein gp120--chemistry
HIV Infections--prevention & control
HIV-1--chemistry
Humans
Peptide Fragments--chemistry
Protein Conformation
Receptors, HIV--antagonists & inhibitors